Larry J. Jolivette

1.1k total citations
20 papers, 400 citations indexed

About

Larry J. Jolivette is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Larry J. Jolivette has authored 20 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Pharmacology and 5 papers in Computational Theory and Mathematics. Recurrent topics in Larry J. Jolivette's work include Pharmacogenetics and Drug Metabolism (6 papers), Computational Drug Discovery Methods (5 papers) and Analytical Chemistry and Chromatography (3 papers). Larry J. Jolivette is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Computational Drug Discovery Methods (5 papers) and Analytical Chemistry and Chromatography (3 papers). Larry J. Jolivette collaborates with scholars based in United States, United Kingdom and China. Larry J. Jolivette's co-authors include Keith W. Ward, Rakesh Nagilla, Sean Ekins, Christopher A. Evans, Katie Ward, M.W. Anders, J. Jeffrey McAtee, Brian G. Lawhorn, Karpagam Aravindhan and Robert N. Willette and has published in prestigious journals such as Nature Communications, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Larry J. Jolivette

18 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry J. Jolivette United States 12 141 115 106 73 70 20 400
James Atherton United States 10 115 0.8× 135 1.2× 40 0.4× 55 0.8× 80 1.1× 11 405
Nathan X. Yu United States 7 140 1.0× 138 1.2× 41 0.4× 29 0.4× 98 1.4× 13 381
Rakesh Nagilla United States 12 263 1.9× 117 1.0× 74 0.7× 51 0.7× 130 1.9× 27 649
Andrew P. Blanchard United States 6 140 1.0× 351 3.1× 99 0.9× 41 0.6× 144 2.1× 8 535
Konstantine W. Skordos United States 9 168 1.2× 301 2.6× 87 0.8× 48 0.7× 164 2.3× 10 501
James E. Grace United States 13 145 1.0× 152 1.3× 83 0.8× 34 0.5× 82 1.2× 21 555
Wenjie Lu China 10 118 0.8× 88 0.8× 41 0.4× 43 0.6× 87 1.2× 24 394
Riccardo Vianello Italy 2 193 1.4× 164 1.4× 179 1.7× 68 0.9× 26 0.4× 2 360
Ryan Takahashi United States 13 173 1.2× 189 1.6× 47 0.4× 28 0.4× 129 1.8× 31 443
Eiji Kashiyama Japan 12 185 1.3× 134 1.2× 55 0.5× 210 2.9× 100 1.4× 24 623

Countries citing papers authored by Larry J. Jolivette

Since Specialization
Citations

This map shows the geographic impact of Larry J. Jolivette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry J. Jolivette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry J. Jolivette more than expected).

Fields of papers citing papers by Larry J. Jolivette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry J. Jolivette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry J. Jolivette. The network helps show where Larry J. Jolivette may publish in the future.

Co-authorship network of co-authors of Larry J. Jolivette

This figure shows the co-authorship network connecting the top 25 collaborators of Larry J. Jolivette. A scholar is included among the top collaborators of Larry J. Jolivette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry J. Jolivette. Larry J. Jolivette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dhruv, Harshil, Qiaolin Deng, Matthew Tudor, et al.. (2025). Discovery of a Novel Series of iso-Indolinone-Based Glutarimides as Highly Efficacious and Selective IKZF2 Molecular Glue Degraders. Journal of Medicinal Chemistry. 68(17). 18230–18257.
2.
Chen, Zhixiang, Harshil Dhruv, Xuqing Zhang, et al.. (2025). Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy. Nature Communications. 16(1). 4095–4095. 6 indexed citations
3.
Zhang, Xuqing, Qiaolin Deng, Harshil Dhruv, et al.. (2025). Overcoming CK1α liability in the discovery of a series of isoIndolinone Glutarimides as selective IKZF2 molecular glue degraders. Bioorganic & Medicinal Chemistry Letters. 124. 130263–130263. 1 indexed citations
4.
5.
Olzinski, Alan R., Larry J. Jolivette, Timothy W. Sikorski, et al.. (2023). Development of an LC–MS/MS Assay for Quantification of intact INSL3 in Rat Plasma. Bioanalysis. 15(19). 1169–1178.
6.
Patterson, Jaclyn R., Lamont R. Terrell, Carla A. Donatelli, et al.. (2020). Design and Optimization of an Acyclic Amine Series of TRPV4 Antagonists by Electronic Modulation of Hydrogen Bond Interactions. Journal of Medicinal Chemistry. 63(23). 14867–14884. 10 indexed citations
7.
Behm, David J., Edward J. Brnardic, Melissa H. Costell, et al.. (2019). Discovery of GSK3527497: A Candidate for the Inhibition of Transient Receptor Potential Vanilloid-4 (TRPV4). Journal of Medicinal Chemistry. 62(20). 9270–9280. 19 indexed citations
8.
Lawhorn, Brian G., Alan P. Graves, Lisa M. Shewchuk, et al.. (2018). 4,6-Diaminopyrimidines as Highly Preferred Troponin I-Interacting Kinase (TNNI3K) Inhibitors. Journal of Medicinal Chemistry. 61(7). 3076–3088. 23 indexed citations
9.
Bao, Weike, Gavin C. Jones, Karpagam Aravindhan, et al.. (2013). Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat. Cardiovascular Diabetology. 12(1). 148–148. 44 indexed citations
10.
11.
Sehon, Clark A., Andrew Q. Viet, Krista Goodman, et al.. (2008). Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases. Journal of Medicinal Chemistry. 51(21). 6631–6634. 63 indexed citations
12.
Jolivette, Larry J. & Sean Ekins. (2006). Methods for Predicting Human Drug Metabolism. Advances in clinical chemistry. 43. 131–176. 29 indexed citations
13.
Evans, Christopher A., Larry J. Jolivette, Rakesh Nagilla, & Keith W. Ward. (2006). EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF “DISCOVERY-LIKE” MOLECULES TO PREDICT HUMAN PHARMACOKINETICS. Drug Metabolism and Disposition. 34(7). 1255–1265. 28 indexed citations
14.
Jolivette, Larry J. & Keith W. Ward. (2005). Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. Journal of Pharmaceutical Sciences. 94(7). 1467–1483. 72 indexed citations
15.
Nagilla, Rakesh, et al.. (2005). Investigation of the utility of published in vitro intrinsic clearance data for prediction of in vivo clearance. Journal of Pharmacological and Toxicological Methods. 53(2). 106–116. 26 indexed citations
16.
Ward, Katie, Rakesh Nagilla, & Larry J. Jolivette. (2005). Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human. Xenobiotica. 35(2). 191–210. 29 indexed citations
17.
Yan, Hongxing, Jeffrey K. Kerns, Qi Jin, et al.. (2005). A Highly Convergent Synthesis of 2‐Phenyl Quinoline as Dual Antagonists for NK2 and NK3 Receptors. Synthetic Communications. 35(24). 3105–3112. 11 indexed citations
18.
19.
Jolivette, Larry J. & M.W. Anders. (2002). Structure−Activity Relationship for the Biotransformation of Haloalkenes by Rat Liver Microsomal Glutathione Transferase 1. Chemical Research in Toxicology. 15(8). 1036–1041. 13 indexed citations
20.
Jolivette, Larry J., Andrew S. Kende, & M.W. Anders. (1998). Thietanium Ion Formation from the Food Mutagen 2-Chloro-4-(methylthio)butanoic Acid. Chemical Research in Toxicology. 11(7). 794–799. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Atherton Breakdown of academic impact, for papers by Nathan X. Yu Breakdown of academic impact, for papers by Rakesh Nagilla Breakdown of academic impact, for papers by Andrew P. Blanchard Breakdown of academic impact, for papers by Konstantine W. Skordos Breakdown of academic impact, for papers by James E. Grace Breakdown of academic impact, for papers by Wenjie Lu Breakdown of academic impact, for papers by Riccardo Vianello Breakdown of academic impact, for papers by Ryan Takahashi Breakdown of academic impact, for papers by Eiji Kashiyama
Rankless by CCL
2026